[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Report 2017

October 2017 | 108 pages | ID: U2D9BA06274EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States High Potency Active Pharmaceutical Ingredients (HPAPI) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of High Potency Active Pharmaceutical Ingredients (HPAPI) in these regions, from 2012 to 2022 (forecast).
United States High Potency Active Pharmaceutical Ingredients (HPAPI) market competition by top manufacturers/players, with High Potency Active Pharmaceutical Ingredients (HPAPI) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Eli Lilly and Company
  • Novartis International AG
  • Bristol-Myers Squibb Company
  • Roche Diagnostics Limited
  • Sanofi Aventis
  • Hospira, Inc.
  • BASF AG
  • Covidien Plc
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Sigma Aldrich Corporation
  • Bayer AG
  • Carbogen Amcis AG
  • Lonza
  • Teva Pharmaceuticals Industries Ltd.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Synthetic
  • Biotech
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of High Potency Active Pharmaceutical Ingredients (HPAPI) for each application, including
  • Oncology
  • Hormonal
  • Glaucoma
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Report 2017

1 HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS (HPAPI) OVERVIEW

1.1 Product Overview and Scope of High Potency Active Pharmaceutical Ingredients (HPAPI)
1.2 Classification of High Potency Active Pharmaceutical Ingredients (HPAPI) by Product Category
  1.2.1 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Synthetic
  1.2.4 Biotech
1.3 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market by Application/End Users
  1.3.1 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Oncology
  1.3.3 Hormonal
  1.3.4 Glaucoma
  1.3.5 Others
1.4 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market by Region
  1.4.1 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West High Potency Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2012-2022)
  1.4.3 Southwest High Potency Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic High Potency Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2012-2022)
  1.4.5 New England High Potency Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2012-2022)
  1.4.6 The South High Potency Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2012-2022)
  1.4.7 The Midwest High Potency Active Pharmaceutical Ingredients (HPAPI) Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of High Potency Active Pharmaceutical Ingredients (HPAPI) (2012-2022)
  1.5.1 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales and Growth Rate (2012-2022)
  1.5.2 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2022)

2 UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS (HPAPI) MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Average Price by Players/Suppliers (2012-2017)
2.4 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Competitive Situation and Trends
  2.4.1 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Concentration Rate
  2.4.2 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers High Potency Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS (HPAPI) SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales and Market Share by Region (2012-2017)
3.2 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue and Market Share by Region (2012-2017)
3.3 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Price by Region (2012-2017)

4 UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS (HPAPI) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue and Market Share by Type (2012-2017)
4.3 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Price by Type (2012-2017)
4.4 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS (HPAPI) SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales and Market Share by Application (2012-2017)
5.2 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS (HPAPI) PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Eli Lilly and Company
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis International AG
  6.2.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis International AG High Potency Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bristol-Myers Squibb Company
  6.3.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bristol-Myers Squibb Company High Potency Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Roche Diagnostics Limited
  6.4.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Roche Diagnostics Limited High Potency Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi Aventis
  6.5.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Aventis High Potency Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Hospira, Inc.
  6.6.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Hospira, Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 BASF AG
  6.7.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 BASF AG High Potency Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Covidien Plc
  6.8.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Covidien Plc High Potency Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Boehringer Ingelheim GmbH
  6.9.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Boehringer Ingelheim GmbH High Potency Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Merck & Co., Inc.
  6.10.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Merck & Co., Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Sigma Aldrich Corporation
6.12 Bayer AG
6.13 Carbogen Amcis AG
6.14 Lonza
6.15 Teva Pharmaceuticals Industries Ltd.

7 HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS (HPAPI) MANUFACTURING COST ANALYSIS

7.1 High Potency Active Pharmaceutical Ingredients (HPAPI) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredients (HPAPI)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 High Potency Active Pharmaceutical Ingredients (HPAPI) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of High Potency Active Pharmaceutical Ingredients (HPAPI) Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS (HPAPI) MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume, Revenue Forecast (2017-2022)
11.2 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume Forecast by Type (2017-2022)
11.3 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume Forecast by Application (2017-2022)
11.4 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of High Potency Active Pharmaceutical Ingredients (HPAPI)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (K Units) by Type (2012-2022)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (Product Category) in 2016
Figure Synthetic Product Picture
Figure Biotech Product Picture
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of High Potency Active Pharmaceutical Ingredients (HPAPI) by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Hormonal Examples
Table Key Downstream Customer in Hormonal
Figure Glaucoma Examples
Table Key Downstream Customer in Glaucoma
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD) by Region (2012-2022)
Figure The West High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales (K Units) and Growth Rate (2012-2022)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Share by Players/Suppliers
Figure 2017 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Share by Players/Suppliers
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Players/Suppliers
Figure 2017 United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Players/Suppliers
Table United States Market High Potency Active Pharmaceutical Ingredients (HPAPI) Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market High Potency Active Pharmaceutical Ingredients (HPAPI) Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share of Top 3 Players/Suppliers
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers High Potency Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales (K Units) by Region (2012-2017)
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Share by Region (2012-2017)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Share by Region (2012-2017)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Region in 2016
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Region (2012-2017)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Region (2012-2017)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Region in 2016
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Price (USD/Unit) by Region (2012-2017)
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales (K Units) by Type (2012-2017)
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Share by Type (2012-2017)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Share by Type (2012-2017)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Type in 2016
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of High Potency Active Pharmaceutical Ingredients (HPAPI) by Type (2012-2017)
Figure Revenue Market Share of High Potency Active Pharmaceutical Ingredients (HPAPI) by Type in 2016
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Price (USD/Unit) by Types (2012-2017)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate by Type (2012-2017)
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales (K Units) by Application (2012-2017)
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application (2012-2017)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application (2012-2017)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application in 2016
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate by Application (2012-2017)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate by Application (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (HPAPI) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in United States (2012-2017)
Table Novartis International AG Basic Information List
Table Novartis International AG High Potency Active Pharmaceutical Ingredients (HPAPI) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis International AG High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)
Figure Novartis International AG High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in United States (2012-2017)
Figure Novartis International AG High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company High Potency Active Pharmaceutical Ingredients (HPAPI) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Company High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in United States (2012-2017)
Table Roche Diagnostics Limited Basic Information List
Table Roche Diagnostics Limited High Potency Active Pharmaceutical Ingredients (HPAPI) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Diagnostics Limited High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)
Figure Roche Diagnostics Limited High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in United States (2012-2017)
Figure Roche Diagnostics Limited High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in United States (2012-2017)
Table Sanofi Aventis Basic Information List
Table Sanofi Aventis High Potency Active Pharmaceutical Ingredients (HPAPI) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Aventis High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)
Figure Sanofi Aventis High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in United States (2012-2017)
Figure Sanofi Aventis High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in United States (2012-2017)
Table Hospira, Inc. Basic Information List
Table Hospira, Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hospira, Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)
Figure Hospira, Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in United States (2012-2017)
Figure Hospira, Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in United States (2012-2017)
Table BASF AG Basic Information List
Table BASF AG High Potency Active Pharmaceutical Ingredients (HPAPI) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BASF AG High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)
Figure BASF AG High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in United States (2012-2017)
Figure BASF AG High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in United States (2012-2017)
Table Covidien Plc Basic Information List
Table Covidien Plc High Potency Active Pharmaceutical Ingredients (HPAPI) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Covidien Plc High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)
Figure Covidien Plc High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in United States (2012-2017)
Figure Covidien Plc High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH High Potency Active Pharmaceutical Ingredients (HPAPI) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim GmbH High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in United States (2012-2017)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in United States (2012-2017)
Figure Merck & Co., Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in United States (2012-2017)
Table Sigma Aldrich Corporation Basic Information List
Table Bayer AG Basic Information List
Table Carbogen Amcis AG Basic Information List
Table Lonza Basic Information List
Table Teva Pharmaceuticals Industries Ltd. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of High Potency Active Pharmaceutical Ingredients (HPAPI)
Figure Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredients (HPAPI)
Figure High Potency Active Pharmaceutical Ingredients (HPAPI) Industrial Chain Analysis
Table Raw Materials Sources of High Potency Active Pharmaceutical Ingredients (HPAPI) Major Players/Suppliers in 2016
Table Major Buyers of High Potency Active Pharmaceutical Ingredients (HPAPI)
Table Distributors/Traders List
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Price (USD/Unit) Trend Forecast (2017-2022)
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K Units) Forecast by Type in 2022
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K Units) Forecast by Application in 2022
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume Share Forecast by Region (2017-2022)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume Share Forecast by Region (2017-2022)
Figure United States High Potency Active Pharmaceutical Ingredients (HPAPI) Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories